beatAML: beatAML

beatAMLR Documentation

beatAML

Description

The Beat AML program produced a comprehensive dataset on acute myeloid leukemia (AML) that included genomic data (i.e., whole-exome sequencing and RNA sequencing), ex vivo drug response, and clinical data. We have included only the drug response data from this program in this package.

Usage

beatAML

Format

A tibble with three variables:

inhibitor

names of inhibitors

patient_id

anonymous patient ID

median

the median of drug response at corresponding inhibitor and patient_id

Source

Tyner, Jeffrey W., et al.(2018), Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature 562 (7728): 526–31. http://vizome.org/aml/


NIMAA documentation built on April 11, 2022, 5:05 p.m.